首页 > 最新文献

Cardiology and cardiovascular medicine最新文献

英文 中文
Subclinical Left Ventricular Disfunction in Obese Children: Are we Late? 肥胖儿童的亚临床左心室功能障碍:我们迟到了吗?
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920345
B Riaño-Mendez, M Ruiz-del Campo, P Garcia-Navas, A Ibiricu-Lecumberri, MY Ruiz-del Prado
Aim: Longitudinal global strain (LGS) is reduced in obese patients with preserved ejection fraction of the left ventricle (LV). TAPSE/PAPS ratio, recently described, may be a step forward a more efficient RV function evaluation. The aim of the present study was to screen left and right subclinical dysfunction in obese pediatric patients without comorbidities.
目的:纵向总应变(LGS)降低肥胖患者保留左心室(LV)射血分数。最近描述的TAPSE/PAPS比率可能是更有效的RV功能评估的一步。本研究的目的是筛选没有合并症的肥胖儿童患者的左、右亚临床功能障碍。
{"title":"Subclinical Left Ventricular Disfunction in Obese Children: Are we Late?","authors":"B Riaño-Mendez, M Ruiz-del Campo, P Garcia-Navas, A Ibiricu-Lecumberri, MY Ruiz-del Prado","doi":"10.26502/fccm.92920345","DOIUrl":"https://doi.org/10.26502/fccm.92920345","url":null,"abstract":"Aim: Longitudinal global strain (LGS) is reduced in obese patients with preserved ejection fraction of the left ventricle (LV). TAPSE/PAPS ratio, recently described, may be a step forward a more efficient RV function evaluation. The aim of the present study was to screen left and right subclinical dysfunction in obese pediatric patients without comorbidities.","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"111 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136003954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subclinical Carditis in Acute Rheumatic Fever: A Single Center Experience 急性风湿热的亚临床心炎:单一中心经验
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920341
Md. Saidul Alam, Mohammad Abdul Hye, Shuperna Ahmed, Md. Aminul Islam, Mustanshirah Lubna, B. Bhattacharjee, Md Arifur Rahman, M. Jobayer
Background: Acute rheumatic fever (ARF) is an important public health problem in developing countries. Subclinical carditis (SCC) that is detected only by echocardiogram without audible heart murmurs is relatively common in ARF. The aim of this study was to determine the pattern of SCC in patients of ARF in a specialized center in Bangladesh. Methods : This cross-sectional study was conducted from April 2019 to May 2021 at the National Center for Control of Rheumatic Fever and Heart Diseases. Hundred consecutive diagnosed patients of acute rheumatic fever with SCC were included in the study. Diagnosis of ARF was done according to the revised Jones criteria in 2015. A total of 362 clinically suspected patients of ARF were screened and among them, 100 patients were detected of having SCC by Doppler echocardiography. Results: Mean age of patients with ARF and SCC was 11.8 ±3.6 years and 10.8 ±3.3 years respectively and female was predominant (52.6% in ARF and 57.7% in SCC). Majority of patients (94%) with SCC had a mitral valve involvement and isolated mitral regurgitation was the most common (84%) valvular lesion. Detected valvular lesions mostly were not severe; all the aortic regurgitation and almost all mitral regurgitation (98.8%) were mild and trivial in nature of severity. Conclusion: Common presence of SCC among ARF patients in our study agreed with the recommendations of revised Jones Criteria. Therefore, it is suggested that echocardiography should be done in every suspected patient with ARF for early detection of subclinical carditis and to reduce
背景:急性风湿热(ARF)是发展中国家一个重要的公共卫生问题。亚临床心炎(SCC)仅通过超声心动图检测而无听得见心脏杂音,在ARF中相对常见。本研究的目的是确定在孟加拉国的一个专门中心的ARF患者的SCC的模式。方法:本横断面研究于2019年4月至2021年5月在国家风湿热和心脏病控制中心进行。研究纳入了连续诊断为急性风湿热伴SCC的100例患者。2015年根据修订后的Jones标准进行ARF诊断。共筛查临床疑似ARF患者362例,其中100例经多普勒超声心动图检出SCC。结果:ARF和SCC患者的平均年龄分别为11.8±3.6岁和10.8±3.3岁,女性居多(ARF为52.6%,SCC为57.7%)。大多数SCC患者(94%)累及二尖瓣,单纯性二尖瓣返流是最常见的(84%)瓣膜病变。所检出的瓣膜病变多不严重;所有的主动脉瓣反流和几乎所有的二尖瓣反流(98.8%)在严重程度上都是轻微和微不足道的。结论:在我们的研究中,ARF患者中普遍存在SCC,这与修订后的Jones标准的建议一致。因此,建议每个疑似ARF患者都应进行超声心动图检查,以早期发现亚临床心炎并减少其发生
{"title":"Subclinical Carditis in Acute Rheumatic Fever: A Single Center Experience","authors":"Md. Saidul Alam, Mohammad Abdul Hye, Shuperna Ahmed, Md. Aminul Islam, Mustanshirah Lubna, B. Bhattacharjee, Md Arifur Rahman, M. Jobayer","doi":"10.26502/fccm.92920341","DOIUrl":"https://doi.org/10.26502/fccm.92920341","url":null,"abstract":"Background: Acute rheumatic fever (ARF) is an important public health problem in developing countries. Subclinical carditis (SCC) that is detected only by echocardiogram without audible heart murmurs is relatively common in ARF. The aim of this study was to determine the pattern of SCC in patients of ARF in a specialized center in Bangladesh. Methods : This cross-sectional study was conducted from April 2019 to May 2021 at the National Center for Control of Rheumatic Fever and Heart Diseases. Hundred consecutive diagnosed patients of acute rheumatic fever with SCC were included in the study. Diagnosis of ARF was done according to the revised Jones criteria in 2015. A total of 362 clinically suspected patients of ARF were screened and among them, 100 patients were detected of having SCC by Doppler echocardiography. Results: Mean age of patients with ARF and SCC was 11.8 ±3.6 years and 10.8 ±3.3 years respectively and female was predominant (52.6% in ARF and 57.7% in SCC). Majority of patients (94%) with SCC had a mitral valve involvement and isolated mitral regurgitation was the most common (84%) valvular lesion. Detected valvular lesions mostly were not severe; all the aortic regurgitation and almost all mitral regurgitation (98.8%) were mild and trivial in nature of severity. Conclusion: Common presence of SCC among ARF patients in our study agreed with the recommendations of revised Jones Criteria. Therefore, it is suggested that echocardiography should be done in every suspected patient with ARF for early detection of subclinical carditis and to reduce","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"119 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thromboembolism in the Complications of Long COVID-19. 新型冠状病毒肺炎并发症中的血栓栓塞。
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920317
Leilani A Lopes, Devendra K Agrawal

SARS-CoV-2 is a +ssRNA helical coronavirus responsible for the global pandemic caused by coronavirus disease 19 (COVID-19). Classical clinical symptoms from primary COVID-19 when symptomatic include cough, fever, pneumonia or even ARDS; however, they are limited primarily to the respiratory system. Long-COVID-19 sequalae is responsible for many pathologies in almost every organ system and may be present in up to 30% of patients who have developed COVID-19. Our review focuses on how long-COVID-19 (3 -24 weeks after primary symptoms) may lead to an increased risk for stroke and thromboembolism. Patients who were found to be primarily at risk for thrombotic events included critically ill and immunocompromised patients. Additional risk factors for thromboembolism and stroke included diabetes, hypertension, respiratory and cardiovascular disease, and obesity. The etiology of how long-COVID-19 leads to a hypercoagulable state are yet to be definitively elucidated. However, anti-phospholipid antibodies and elevated D-dimer are present in many patients who develop thromboembolism. In addition, chronic upregulation and exhaustion of the immune system may lead to a pro-inflammatory and hypercoagulable state, increasing the likelihood for induction of thromboembolism or stroke. This article provides an up-to-date review on the proposed etiologies for thromboembolism and stroke in patients with long-COVID-19 and to assist health care providers in examining patients who may be at a higher risk for developing these pathologies.

SARS-CoV-2是一种+ssRNA螺旋状冠状病毒,导致冠状病毒病19 (COVID-19)引起的全球大流行。当症状包括咳嗽、发烧、肺炎甚至急性呼吸窘迫综合征时,原发性COVID-19的典型临床症状;然而,它们主要局限于呼吸系统。COVID-19的长期后遗症会导致几乎每个器官系统的许多病理,高达30%的COVID-19患者可能会出现这种后遗症。我们的综述重点关注covid -19(原发性症状后3 -24周)可能导致中风和血栓栓塞风险增加的时间。发现主要存在血栓事件风险的患者包括危重患者和免疫功能低下患者。血栓栓塞和中风的其他危险因素包括糖尿病、高血压、呼吸系统和心血管疾病以及肥胖。covid -19导致高凝状态多长时间的病因尚待明确阐明。然而,抗磷脂抗体和d -二聚体升高存在于许多血栓栓塞患者中。此外,免疫系统的慢性上调和衰竭可能导致促炎和高凝状态,增加诱发血栓栓塞或中风的可能性。本文对长期感染covid -19的患者的血栓栓塞和中风的病原学进行了最新的综述,并协助卫生保健提供者检查可能有较高风险发展这些病理的患者。
{"title":"Thromboembolism in the Complications of Long COVID-19.","authors":"Leilani A Lopes,&nbsp;Devendra K Agrawal","doi":"10.26502/fccm.92920317","DOIUrl":"https://doi.org/10.26502/fccm.92920317","url":null,"abstract":"<p><p>SARS-CoV-2 is a +ssRNA helical coronavirus responsible for the global pandemic caused by coronavirus disease 19 (COVID-19). Classical clinical symptoms from primary COVID-19 when symptomatic include cough, fever, pneumonia or even ARDS; however, they are limited primarily to the respiratory system. Long-COVID-19 sequalae is responsible for many pathologies in almost every organ system and may be present in up to 30% of patients who have developed COVID-19. Our review focuses on how long-COVID-19 (3 -24 weeks after primary symptoms) may lead to an increased risk for stroke and thromboembolism. Patients who were found to be primarily at risk for thrombotic events included critically ill and immunocompromised patients. Additional risk factors for thromboembolism and stroke included diabetes, hypertension, respiratory and cardiovascular disease, and obesity. The etiology of how long-COVID-19 leads to a hypercoagulable state are yet to be definitively elucidated. However, anti-phospholipid antibodies and elevated D-dimer are present in many patients who develop thromboembolism. In addition, chronic upregulation and exhaustion of the immune system may lead to a pro-inflammatory and hypercoagulable state, increasing the likelihood for induction of thromboembolism or stroke. This article provides an up-to-date review on the proposed etiologies for thromboembolism and stroke in patients with long-COVID-19 and to assist health care providers in examining patients who may be at a higher risk for developing these pathologies.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"7 2","pages":"123-128"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9799789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
False Atrial Fibrillation Alerts from Smartwatches are Associated with Decreased Perceived Physical Well-being and Confidence in Chronic Symptoms Management. 智能手表发出的虚假心房颤动警报与身体健康感知和慢性症状管理信心下降有关。
Pub Date : 2023-01-01 Epub Date: 2023-04-03 DOI: 10.26502/fccm.92920314
Khanh-Van Tran, Andreas Filippaios, Kamran Noorishirazi, Eric Ding, Dong Han, Fahimeh Mohagheghian, Qiying Dai, Jordy Mehawej, Ziyue Wang, Darleen Lessard, Edith Mensah Otabil, Alex Hamel, Tenes Paul, Matthew F Gottbrecht, Timothy P Fitzgibbons, Jane Saczynski, Ki H Chon, David D McManus

Wrist-based wearables have been FDA approved for AF detection. However, the health behavior impact of false AF alerts from wearables on older patients at high risk for AF are not known. In this work, we analyzed data from the Pulsewatch (NCT03761394) study, which randomized patients (≥50 years) with history of stroke or transient ischemic attack to wear a patch monitor and a smartwatch linked to a smartphone running the Pulsewatch application vs to only the cardiac patch monitor over 14 days. At baseline and 14 days, participants completed validated instruments to assess for anxiety, patient activation, perceived mental and physical health, chronic symptom management self-efficacy, and medicine adherence. We employed linear regression to examine associations between false AF alerts with change in patient-reported outcomes. Receipt of false AF alerts was related to a dose-dependent decline in self-perceived physical health and levels of disease self-management. We developed a novel convolutional denoising autoencoder (CDA) to remove motion and noise artifacts in photoplethysmography (PPG) segments to optimize AF detection, which substantially reduced the number of false alerts. A promising approach to avoid negative impact of false alerts is to employ artificial intelligence driven algorithms to improve accuracy.

腕式可穿戴设备已获得 FDA 批准用于房颤检测。然而,可穿戴设备发出的错误房颤警报对房颤高危老年患者健康行为的影响尚不清楚。在这项工作中,我们分析了 Pulsewatch(NCT03761394)研究的数据,该研究随机让有中风或短暂性脑缺血发作病史的患者(≥50 岁)在 14 天内佩戴贴片监测仪和与运行 Pulsewatch 应用程序的智能手机相连的智能手表,与只佩戴心脏贴片监测仪进行对比。在基线和 14 天内,参与者完成了评估焦虑、患者激活、身心健康感知、慢性症状管理自我效能和药物依从性的有效工具。我们采用线性回归法研究了错误房颤警报与患者报告结果变化之间的关联。收到虚假房颤警报与自我感觉身体健康和疾病自我管理水平的下降呈剂量依赖关系。我们开发了一种新颖的卷积去噪自动编码器(CDA),用于去除光电血压计(PPG)片段中的运动和噪声伪影,以优化房颤检测,从而大大减少了错误警报的数量。采用人工智能驱动的算法来提高准确性是避免误报负面影响的一种可行方法。
{"title":"False Atrial Fibrillation Alerts from Smartwatches are Associated with Decreased Perceived Physical Well-being and Confidence in Chronic Symptoms Management.","authors":"Khanh-Van Tran, Andreas Filippaios, Kamran Noorishirazi, Eric Ding, Dong Han, Fahimeh Mohagheghian, Qiying Dai, Jordy Mehawej, Ziyue Wang, Darleen Lessard, Edith Mensah Otabil, Alex Hamel, Tenes Paul, Matthew F Gottbrecht, Timothy P Fitzgibbons, Jane Saczynski, Ki H Chon, David D McManus","doi":"10.26502/fccm.92920314","DOIUrl":"10.26502/fccm.92920314","url":null,"abstract":"<p><p>Wrist-based wearables have been FDA approved for AF detection. However, the health behavior impact of false AF alerts from wearables on older patients at high risk for AF are not known. In this work, we analyzed data from the Pulsewatch (NCT03761394) study, which randomized patients (≥50 years) with history of stroke or transient ischemic attack to wear a patch monitor and a smartwatch linked to a smartphone running the Pulsewatch application vs to only the cardiac patch monitor over 14 days. At baseline and 14 days, participants completed validated instruments to assess for anxiety, patient activation, perceived mental and physical health, chronic symptom management self-efficacy, and medicine adherence. We employed linear regression to examine associations between false AF alerts with change in patient-reported outcomes. Receipt of false AF alerts was related to a dose-dependent decline in self-perceived physical health and levels of disease self-management. We developed a novel convolutional denoising autoencoder (CDA) to remove motion and noise artifacts in photoplethysmography (PPG) segments to optimize AF detection, which substantially reduced the number of false alerts. A promising approach to avoid negative impact of false alerts is to employ artificial intelligence driven algorithms to improve accuracy.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"7 2","pages":"97-107"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9862434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidized Low-density Lipoproteins and Lipopolysaccharides Augment Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine. 氧化低密度脂蛋白和脂多糖增加高胆固醇血症微猪颈动脉斑块易损性。
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920338
S Nooti, V Rai, M M Radwan, F G Thankam, H Singh, Y S Chatzizisis, D K Agrawal

Atherosclerosis is a chronic inflammatory disease and hypercholesterolemia is a risk factor. This study aims to compare the potency of lipopolysaccharide (LPS) and oxidized low-density lipoproteins (oxLDL) to induce plaque formation and increase plaque vulnerability in the carotid artery of hypercholesterolemic Yucatan microswine. Atherosclerotic lesions at the common carotid artery junction and ascending pharyngeal artery were induced in hypercholesterolemic Yucatan microswine at 5-6 months of age with balloon angioplasty. LPS or oxLDL were administered intraluminally at the site of injury after occluding the arterial flow temporarily. Pre-intervention ultrasound (US), angiography, and optical coherence tomography (OCT) were done at baseline and just before euthanasia to assess post-op parameters. The images from the US, OCT, and angiography in the LPS and the oxLDL-treated group showed increased plaque formation with features suggestive of unstable plaque, including necrotic core, thin fibrous caps, and a signal poor region more with oxLDL compared to LPS. Histomorphology of the carotid artery tissue near the injury corroborated the presence of severe lesions in both LPS and oxLDL-treated pigs but more in the oxLDL group. Vascular smooth muscle and endothelial cells treated with LPS and oxLDL showed increased folds changes in mRNA transcripts of the biomarkers of inflammation and plaque vulnerability compared to untreated cells. Collectively, the results suggest that angioplasty-mediated intimal injury of the carotid arteries in atherosclerotic swine with local administration of LPS or ox-LDL induces vulnerable plaques compared to angioplasty alone and oxLDL is relatively more potent than LPS in inducing vulnerable plaque.

动脉粥样硬化是一种慢性炎症性疾病,高胆固醇血症是一种危险因素。本研究旨在比较脂多糖(LPS)和氧化低密度脂蛋白(oxLDL)在高胆固醇血症尤卡坦微猪颈动脉诱导斑块形成和增加斑块易易性的作用。用球囊血管成形术对5-6月龄高胆固醇血症尤卡坦微型猪进行颈总动脉连接处和咽升动脉粥样硬化病变的诱导。暂时阻断动脉血流后,在损伤部位静脉内给予LPS或oxLDL。介入前超声(US)、血管造影和光学相干断层扫描(OCT)在基线和安乐死前进行,以评估术后参数。LPS组和oxLDL组的US、OCT和血管造影显示斑块形成增加,伴有不稳定斑块的特征,包括坏死的核心、薄的纤维帽和与LPS相比oxLDL组更多的信号差区。损伤附近的颈动脉组织的组织形态学证实了LPS和oxLDL处理的猪存在严重病变,但oxLDL组的病变更严重。与未处理的细胞相比,LPS和oxLDL处理的血管平滑肌和内皮细胞显示炎症和斑块易损生物标志物mRNA转录物的皱褶变化增加。总的来说,结果表明,与单独血管成形术相比,局部给予LPS或ox-LDL的动脉粥样硬化猪颈动脉血管成形术介导的内膜损伤可诱导易损斑块,oxLDL在诱导易损斑块方面相对比LPS更有效。
{"title":"Oxidized Low-density Lipoproteins and Lipopolysaccharides Augment Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine.","authors":"S Nooti,&nbsp;V Rai,&nbsp;M M Radwan,&nbsp;F G Thankam,&nbsp;H Singh,&nbsp;Y S Chatzizisis,&nbsp;D K Agrawal","doi":"10.26502/fccm.92920338","DOIUrl":"https://doi.org/10.26502/fccm.92920338","url":null,"abstract":"<p><p>Atherosclerosis is a chronic inflammatory disease and hypercholesterolemia is a risk factor. This study aims to compare the potency of lipopolysaccharide (LPS) and oxidized low-density lipoproteins (oxLDL) to induce plaque formation and increase plaque vulnerability in the carotid artery of hypercholesterolemic Yucatan microswine. Atherosclerotic lesions at the common carotid artery junction and ascending pharyngeal artery were induced in hypercholesterolemic Yucatan microswine at 5-6 months of age with balloon angioplasty. LPS or oxLDL were administered intraluminally at the site of injury after occluding the arterial flow temporarily. Pre-intervention ultrasound (US), angiography, and optical coherence tomography (OCT) were done at baseline and just before euthanasia to assess post-op parameters. The images from the US, OCT, and angiography in the LPS and the oxLDL-treated group showed increased plaque formation with features suggestive of unstable plaque, including necrotic core, thin fibrous caps, and a signal poor region more with oxLDL compared to LPS. Histomorphology of the carotid artery tissue near the injury corroborated the presence of severe lesions in both LPS and oxLDL-treated pigs but more in the oxLDL group. Vascular smooth muscle and endothelial cells treated with LPS and oxLDL showed increased folds changes in mRNA transcripts of the biomarkers of inflammation and plaque vulnerability compared to untreated cells. Collectively, the results suggest that angioplasty-mediated intimal injury of the carotid arteries in atherosclerotic swine with local administration of LPS or ox-LDL induces vulnerable plaques compared to angioplasty alone and oxLDL is relatively more potent than LPS in inducing vulnerable plaque.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"7 4","pages":"273-294"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421630/pdf/nihms-1920665.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9996740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Post-Operative Electrocardiographic (ECG) Changes Indicate any Underlying Graft Problem after CABG? Correlation of Early Post-Operative ECG Changes with CT Coronary Angiography (CTCA) 冠状动脉搭桥术后的心电图变化是否表明有潜在的移植物问题?术后早期心电图变化与CT冠状动脉造影(CTCA)的相关性
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920323
Abhishek Rajendra Potnis, S. Potwar, B. Aironi, Dwarkanath Vivekanand Kulkarni, U. E. Jadhav, Gaurish Omprakash Sawant
{"title":"Do Post-Operative Electrocardiographic (ECG) Changes Indicate any Underlying Graft Problem after CABG? Correlation of Early Post-Operative ECG Changes with CT Coronary Angiography (CTCA)","authors":"Abhishek Rajendra Potnis, S. Potwar, B. Aironi, Dwarkanath Vivekanand Kulkarni, U. E. Jadhav, Gaurish Omprakash Sawant","doi":"10.26502/fccm.92920323","DOIUrl":"https://doi.org/10.26502/fccm.92920323","url":null,"abstract":"","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Analysis of CYP2C19 Alleles and Clopidogrel Resistance Among Bangladeshi Patients with Acute Coronary Syndrome 孟加拉国急性冠脉综合征患者CYP2C19等位基因与氯吡格雷耐药性的分子分析
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920321
Mohsin Ahmed, Sayeedur Rahman Khan, Aminur Razzaque, M. Arifur Rahman, S. Islam, Mainul Islam, Monwarul Islam AKM, Mohammad Ullah Firoze, Md. Matiur Rahman, T. Ahmad, Kudrat-E-Khuda Cm, Shiblee Sa
{"title":"Molecular Analysis of CYP2C19 Alleles and Clopidogrel Resistance Among Bangladeshi Patients with Acute Coronary Syndrome","authors":"Mohsin Ahmed, Sayeedur Rahman Khan, Aminur Razzaque, M. Arifur Rahman, S. Islam, Mainul Islam, Monwarul Islam AKM, Mohammad Ullah Firoze, Md. Matiur Rahman, T. Ahmad, Kudrat-E-Khuda Cm, Shiblee Sa","doi":"10.26502/fccm.92920321","DOIUrl":"https://doi.org/10.26502/fccm.92920321","url":null,"abstract":"","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peri-Coronary Sinus Flutter: A Unique Form of an Atypical Atrial Flutter. A Case Report 冠状动脉周围窦性扑动:非典型心房扑动的一种独特形式。病例报告
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920307
A. Ziakos, H. Greiss, Angelis Sezenias, A. Sause
{"title":"Peri-Coronary Sinus Flutter: A Unique Form of an Atypical Atrial Flutter. A Case Report","authors":"A. Ziakos, H. Greiss, Angelis Sezenias, A. Sause","doi":"10.26502/fccm.92920307","DOIUrl":"https://doi.org/10.26502/fccm.92920307","url":null,"abstract":"","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69347292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocarditis in COVID-19 Patients: A Cross-Sectional Study COVID-19患者心肌炎:一项横断面研究
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920316
{"title":"Myocarditis in COVID-19 Patients: A Cross-Sectional Study","authors":"","doi":"10.26502/fccm.92920316","DOIUrl":"https://doi.org/10.26502/fccm.92920316","url":null,"abstract":"","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors 达格列净和西格列汀联合治疗:合并多种心血管危险因素的2型糖尿病的临床应用综述
Pub Date : 2023-01-01 DOI: 10.26502/fccm.92920319
L. Ravikumar, Ravindra S Kiwalkar, R. H. S., Beerakayala Lokesh, Dhammdeep C. Dabhade
Cardiovascular disease remains the leading cause of mortality in patients with diabetes. Control of multiple cardiovascular risk factors in patients with type 2 diabetes mellitus often leads to substantial reduction in adverse cardiovascular events. Newer antihyperglycemic agents at several randomized controlled trials have demonstrated their cardiovascular safety along with reduction in cardiovascular outcomes in type 2 diabetes mellitus with or without heart failure. Sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors reported to have positive CV outcomes; especially, combination therapy with dapagliflozin and sitagliptin seem to be suitable therapeutic option. However, data upon the fixed-dose combination of these agents is limited. This review discusses the rationale and clinical utility of combination therapy with dapagliflozin and sitagliptin in improving glycemic control and reducing cardiovascular events in patients with type 2 diabetes mellitus with multiple cardiovascular risk factors.
心血管疾病仍然是糖尿病患者死亡的主要原因。控制2型糖尿病患者的多种心血管危险因素通常会导致不良心血管事件的显著减少。在一些随机对照试验中,新的降糖药已经证明了它们的心血管安全性,并能降低伴有或不伴有心力衰竭的2型糖尿病患者的心血管结局。据报道,钠-葡萄糖共转运蛋白2抑制剂和二肽基肽酶-4抑制剂具有阳性的CV结果;特别是,达格列净和西格列汀联合治疗似乎是合适的治疗选择。然而,关于这些药物的固定剂量组合的数据有限。本文综述了达格列净和西格列汀联合治疗具有多种心血管危险因素的2型糖尿病患者血糖控制和减少心血管事件的原理和临床应用。
{"title":"Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors","authors":"L. Ravikumar, Ravindra S Kiwalkar, R. H. S., Beerakayala Lokesh, Dhammdeep C. Dabhade","doi":"10.26502/fccm.92920319","DOIUrl":"https://doi.org/10.26502/fccm.92920319","url":null,"abstract":"Cardiovascular disease remains the leading cause of mortality in patients with diabetes. Control of multiple cardiovascular risk factors in patients with type 2 diabetes mellitus often leads to substantial reduction in adverse cardiovascular events. Newer antihyperglycemic agents at several randomized controlled trials have demonstrated their cardiovascular safety along with reduction in cardiovascular outcomes in type 2 diabetes mellitus with or without heart failure. Sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors reported to have positive CV outcomes; especially, combination therapy with dapagliflozin and sitagliptin seem to be suitable therapeutic option. However, data upon the fixed-dose combination of these agents is limited. This review discusses the rationale and clinical utility of combination therapy with dapagliflozin and sitagliptin in improving glycemic control and reducing cardiovascular events in patients with type 2 diabetes mellitus with multiple cardiovascular risk factors.","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69346975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiology and cardiovascular medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1